BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCL2A1 | BCL2-related protein A1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BLK | BLK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
C10orf105 | Chromosome 10 open reading frame 105 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C11orf21 | Chromosome 11 open reading frame 21 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C16orf54 | Chromosome 16 open reading frame 54 | Predicted membrane proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C17orf99 | Chromosome 17 open reading frame 99 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C19orf35 | Chromosome 19 open reading frame 35 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C19orf38 | Chromosome 19 open reading frame 38 | Predicted membrane proteins
| | | | | Tissue enhanced |
C2orf48 | Chromosome 2 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C3AR1 | Complement component 3a receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C5AR2 | Complement component 5a receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
C6orf25 | Chromosome 6 open reading frame 25 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CABP4 | Calcium binding protein 4 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAMP | Cathelicidin antimicrobial peptide | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CARD9 | Caspase recruitment domain family, member 9 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CASS4 | Cas scaffolding protein family member 4 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL14 | Chemokine (C-C motif) ligand 14 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL17 | Chemokine (C-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL22 | Chemokine (C-C motif) ligand 22 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL3 | Chemokine (C-C motif) ligand 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL3L3 | Chemokine (C-C motif) ligand 3-like 3 | Predicted secreted proteins
| | | | | Tissue enriched |
CCL4 | Chemokine (C-C motif) ligand 4 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL4L1 | Chemokine (C-C motif) ligand 4-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CCM2L | Cerebral cavernous malformation 2-like | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNE2 | Cyclin E2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCR1 | Chemokine (C-C motif) receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |